Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.26377 | 51 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.21254 | 51 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.21397 | 51 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.09376 | 49 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.11554 | 49 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.36045 | 52 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.26884 | 50 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.19345 | 50 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.18903 | 50 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.18871 | 50 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.20578 | 50 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.14225 | 49 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.22869 | 51 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.20542 | 50 |